Skip to Content

Join the 'Abnormal Uterine Bleeding' group to help and get support from people like you.

Abnormal Uterine Bleeding News

Related terms: Bleeding, dysfunctional uterine, Dysfunctional uterine bleeding (DUB), Dysfunctional uterine bleeding, DUB

U.S. Maternal Death Rate Is Rising

Posted 8 Aug 2016 by

MONDAY, Aug. 8, 2016 – The number of U.S. women who die during or soon after pregnancy may be higher than previously thought – and it's on the rise, according to a new study. Between 2000 and 2014, the nation's maternal death rate rose by almost 27 percent, researchers found. However, over that time, reporting methods changed, the study authors noted. For every 100,000 live births, nearly 24 women died during, or within 42 days after pregnancy in 2014. That was up from nearly 19 per 100,000 in 2000. The numbers, published online Aug. 8 in Obstetrics & Gynecology, are worse than previous estimates. Federal health officials have already reported a spike in the nation's maternal mortality figures, but they estimated a rate of 16 per 100,000 as recently as 2010. The new findings give a clearer picture of where the United States really stands, according to lead researcher Marian MacDorman, ... Read more

Related support groups: Bleeding Disorder, Abnormal Uterine Bleeding, Delivery, Labor Induction, Premature Labor, Postpartum Bleeding, Cesarean Section, Labor Pain, Labor and Delivery including Augmentation

Gene Tied to Breast Cancer Raises Uterine Cancer Risk Too

Posted 1 Jul 2016 by

THURSDAY, June 30, 2016 – Women with a gene mutation known as BRCA1 have an increased risk for a deadly form of uterine cancer, a new study finds. The BRCA1 gene mutation is already well known for significantly increasing the risk of breast and ovarian cancers. In fact, the risk is so high that some women consider having both breasts, as well as their ovaries, removed to prevent breast and ovarian cancers, the researchers noted. This latest study is the first to find a conclusive link between the mutation and a slight increase in the odds of developing an aggressive uterine cancer, the researchers said. The study authors looked at data from nearly 1,100 U.S. women with BRCA1 or BRCA2 mutations. The women were from the United States and the United Kingdom. Their health was followed for a median of about five years. BRCA2 also raises the risk of breast and ovarian cancers, according to ... Read more

Related support groups: Abnormal Uterine Bleeding, Breast Cancer, Uterine Bleeding, Ovarian Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Common Infection Caused First U.S. Uterus Transplant to Fail, Hospital Says

Posted 8 Apr 2016 by

FRIDAY, April 8, 2016 – A common fungus caused the complication that forced Cleveland Clinic doctors to remove a transplanted uterus from a 26-year-old woman just two weeks after the groundbreaking procedure was performed, hospital officials said Friday. "Preliminary results suggest that the complication was due to an infection caused by an organism that is commonly found in a woman's reproductive system," Cleveland Clinic doctors said in a statement. "The infection appears to have compromised the blood supply to the uterus, causing the need for its removal." The transplant, the first of its kind in the United States, was performed on Feb. 24. The organ was removed on March 9. The bacteria involved causes vaginal yeast infections. It is not known whether the infection was caused by bacteria from the recipient or the donor, since some of the donor's vaginal tissue was involved in the ... Read more

Related support groups: Abnormal Uterine Bleeding, Female Infertility, Organ Transplant, Candida Urinary Tract Infection

FDA OKs 'Containment' Bag for Certain Uterine Surgeries

Posted 7 Apr 2016 by

THURSDAY, April 7, 2016 – The U.S. Food and Drug Administration on Thursday said it would permit limited use of a "tissue containment system" in conjunction with laparoscopic power morcellators – devices that grind up tissue in gynecological surgeries. But the FDA still warns against using laparoscopic power morcellators in most women because the procedure can spread undetected cancer cells. The device, called the PneumoLiner, will be permitted only when uterine tissue is not suspected to contain cancer, the agency said. And its maker must warn patients and doctors that the device has not been proven to reduce the risk of spreading cancer during these procedures. "The PneumoLiner is intended to contain morcellated tissue in the very limited patient population for whom power morcellation may be an appropriate therapeutic option – and only if patients have been appropriately informed ... Read more

Related support groups: Surgery, Cancer, Abnormal Uterine Bleeding, Hysterectomy, Uterine Leiomyomata / Fibroids, Urinary Tract Cancer, Genitourinary Surgical and Other Conditions

First U.S. Uterus Transplant Patient Grateful for Chance to Have Children

Posted 8 Mar 2016 by

MONDAY, March 7, 2016 – The first American woman to receive a uterus transplant said Monday that she is grateful for the chance to try to have a child. Speaking at a morning news conference two weeks after her surgery, the 26-year-old woman – identified only as Lindsey – said that although she and her husband have adopted three kids, she has still longed to give birth to her own child. "At 16, I was told I would never have children. From that moment on, I prayed that God would allow me the opportunity to experience pregnancy," she said. The Cleveland Clinic doctors who performed the transplant said they plan to do nine more such transplants as part of a research study. The uteruses will come from deceased organ donors. In Lindsey's case, the uterus came from a woman in her 30s who died suddenly. "Our first transplant took place on Feb. 24, and our patient is doing very well," Dr. ... Read more

Related support groups: Abnormal Uterine Bleeding, Female Infertility, Organ Transplant - Rejection Prophylaxis, Organ Transplant, Primary Ovarian Failure

FDA Orders 'Black Box' Warning Label on Essure Long-Acting Contraceptive

Posted 1 Mar 2016 by

MONDAY, Feb. 29, 2016 – A special "black box" warning should be added to packaging for the Essure implantable birth control device, based on concerns over serious complications, the U.S. Food and Drug Administration announced Monday. The FDA also ordered Essure's manufacturer, Bayer, to conduct a new clinical study to gather more data about the health risks the device might pose for "in a real-world environment." Essure is a permanent and nonsurgical form of birth control for women. It consists of flexible coils that are inserted through the vagina and cervix into the fallopian tubes, the FDA explained in a statement. Scar tissue forms naturally around the coils, creating a barrier intended to prevent sperm from reaching the egg as they travel down the fallopian tubes into the uterus. However, since the FDA approved Essure in 2002, the agency says it has received about 10,000 ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Sprintec, NuvaRing, Provera, Implanon, Nexplanon, Depo-Provera, Ortho Tri-Cyclen, Tri-Sprintec, Abnormal Uterine Bleeding, Yasmin, Microgestin Fe 1/20, Loestrin 24 Fe, Ortho Evra, Plan B One-Step, TriNessa

Surgeons Perform First U.S. Uterus Transplant

Posted 26 Feb 2016 by

FRIDAY, Feb. 26, 2016 – Cleveland Clinic surgeons this week performed the nation's first uterus transplant, an experimental procedure offering women without a womb the possibility of pregnancy. The transplanted uterus came from a deceased donor, and the 26-year-old recipient was in stable condition following the nine-hour procedure, her doctors said Thursday. "Cleveland Clinic began screening candidates for uterus transplants late last year," according to a hospital news release. Women who might be candidates for such a transplant have ovaries but were either born without a uterus, have lost it or have suffered irreversible uterine damage, the hospital explained. The condition, called uterine factor infertility, affects 3 percent to 5 percent of women worldwide. One expert not involved in the procedure said it was a real advance for these patients. "The procedure is groundbreaking for ... Read more

Related support groups: Abnormal Uterine Bleeding, Delivery, Uterine Bleeding, Uterine Leiomyomata / Fibroids, Organ Transplant - Rejection Prophylaxis, Organ Transplant, Diagnosis and Investigation, Cesarean Section, Labor Pain, Body Imaging, Rejection Prophylaxis, Labor and Delivery including Augmentation

Black Women Less Likely to Survive Uterine Cancer, Study Finds

Posted 19 Aug 2015 by

WEDNESDAY, Aug. 19, 2015 – Uterine cancer rates are rising in the United States, particularly among black and Asian women, according to a new study that also found black women are more likely to die of the disease. Researchers analyzed more than 120,000 cases of uterine cancer diagnosed in the United States between 2000 and 2011, and found that rates rose among all racial and ethnic groups. But rates increased fastest, at 2.5 percent a year, among black and Asian women. Black women also had higher rates of aggressive uterine cancer than Asian, Hispanic and white women, and death rates for aggressive uterine cancer were more than 1.5 times higher among black women than among white women. Death rates for aggressive uterine cancer were similar or lower among Asian and Hispanic women, compared to white women. A five-year analysis found that black women had poorer survival rates than white ... Read more

Related support groups: Cancer, Abnormal Uterine Bleeding, Uterine Bleeding, Uterine Leiomyomata / Fibroids, Endometrial Cancer

Many U.S. Women Live Far From Gynecologic Cancer Care

Posted 15 Jun 2015 by

MONDAY, June 15, 2015 – Millions of American women have poor access to gynecologic cancer care, a new study finds. The analysis showed that 36 percent of counties in the United States are more than 50 miles from the nearest doctor specializing in ovarian, uterine and cervical cancer. About 10 percent of American women – nearly 15 million – live in those counties, researchers found. "This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes – including misdiagnoses and late detection – as a result of limited access to specialized gynecologic cancer care," said study author Dr. David Shalowitz, a fellow in the University of Pennsylvania School of Medicine's division of gynecologic oncology, in Philadelphia. "Based on our estimates, it's likely that more than 7,000 women with gynecologic ... Read more

Related support groups: Abnormal Uterine Bleeding, Menstrual Disorders, Polycystic Ovary Syndrome, Endometriosis, Ovarian Cysts, Uterine Bleeding, Ovarian Cancer, Cervical Cancer, Pelvic Inflammatory Disease, Gynecological Conditions, Cervical Dysplasia

Mediterranean Diet Tied to Lower Odds of Uterine Cancer

Posted 27 May 2015 by

WEDNESDAY, May 27, 2015 – Adhering to a Mediterranean diet may significantly reduce a woman's risk of uterine cancer, a new study suggests. "Our research shows the impact a healthy, balanced diet could have on a woman's risk of developing womb [uterine] cancer. This adds more weight to our understanding of how our everyday choices, like what we eat and how active we are, affect our risk of cancer," study author Cristina Bosetti, of the IRCCS-Istituto di Ricerche Farmacologiche in Milan, Italy, said in a Cancer Research UK news release. Bosetti's team analyzed the diets of more than 5,000 Italian women to determine how well they followed the Mediterranean diet. In general, the diet emphasizes eating vegetables, fruits, nuts, cereals, potatoes, fish and monounsaturated fats, along with moderate alcohol intake, and cutting back on meat and dairy products. Women who followed seven of the ... Read more

Related support groups: Abnormal Uterine Bleeding, Endometrial Cancer

Simple Test Might Predict Whether Some Pregnancies Succeed

Posted 28 Sep 2012 by

FRIDAY, Sept. 28 – Measuring progesterone levels in women with pain or bleeding during early pregnancy may help determine whether or not the pregnancy is viable, a new study says. A viable pregnancy means that there is a reasonable expectation that it will result in a live birth. Progesterone is a hormone that plays a key role in pregnancy. About one-third of women experience vaginal bleeding or pain in early pregnancy. Ultrasound is used to determine pregnancy viability but this test can sometimes be inconclusive, the authors of the new study pointed out. Along with Dutch colleagues, researchers at the University of Birmingham in England analyzed the findings of 26 studies involving more than 9,400 pregnant women. Seven of the studies included women with pain or bleeding and an inconclusive ultrasound result, and 19 studies included women with pain or bleeding and no ultrasound. The ... Read more

Related support groups: Abnormal Uterine Bleeding, Threatened Abortion

Ask a Question

Further Information

Related Condition Support Groups

Abortion, Threatened Abortion, Uterine Bleeding

Related Drug Support Groups

Mirena, Sprintec, Provera, Depo-Provera, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1 / 20, Loestrin 24 Fe, TriNessa, view more... Lutera, Mononessa, Ortho Tri-Cyclen Lo, Premarin, Aviane, Seasonique, medroxyprogesterone, levonorgestrel, Levora, Nordette, Levlen, Junel Fe 1 / 20, Alesse, norethindrone, Triphasil, Previfem, Gildess Fe 1 / 20, Jolessa, Sronyx, Ortho Cyclen, Cryselle 28, Ogestrel, Orsythia, Microgestin 1 / 20, Necon 1 / 35, Jolivette, Ovral, Tri-Previfem, Ortho Micronor, Microgestin FE 1.5 / 30, Low-Ogestrel-28, Ogestrel-28, Nora-Be, Errin, megestrol, Chateal, Quasense, Megace, Trivora, generess fe, Camila, Seasonale, Zovia, LoSeasonique, Femhrt, Portia, Microgestin 1.5 / 30, Cenestin, ethinyl estradiol / norethindrone, Ovral-28, Tri-Linyah, ethinyl estradiol / norgestimate, Lessina, ethinyl estradiol / levonorgestrel, Enjuvia, Alesse-28, Estarylla, Junel Fe 1.5 / 30, Loestrin 1 / 20, Jinteli, Lo / Ovral-28, Tri-Estarylla, TriNessa Lo, desogestrel / ethinyl estradiol, Balziva, Lybrel, Femcon FE, Ortho-Novum 7 / 7 / 7, Enpresse, Lyza, Lo / Ovral, Aygestin, Junel 1 / 20, Heather, Ortho-Novum 1 / 35, Triphasil-28, Tilia Fe, Loestrin Fe 1 / 20, Depo-Provera Contraceptive, Tri-Lo-Sprintec, Mono-Linyah, Necon 7 / 7 / 7, Falmina, Nortrel 7 / 7 / 7, Estrostep Fe, Megace ES, Nor-QD, Triquilar 28, Nortrel 1 / 35, Amethia Lo, Tri-Lo-Marzia, Alyacen 1 / 35, Low-Ogestrel-21, Elinest, conjugated estrogens, Leena, Sharobel, Triquilar 21, Kelnor, Trivora-28, Ovcon 35, Gildagia, Tri-Legest Fe, Modicon, Zovia 1 / 35, Loestrin Fe 1.5 / 30, Nordette-21, Junel 1.5 / 30, Preven EC, Norinyl 1+35, CamreseLo, Tri-Norinyl, Zeosa, Tri-Legest, Loestrin 21 1 / 20, Premarin Intravenous, Ortho-Novum 1 / 50, Necon 1 / 50, Zovia 1 / 50, ergonovine, Jencycla, Ovcon 35 Fe, depo-subQ provera 104, Cyclafem 1 / 35, Alesse-21, Aranelle, Zenchent Fe, Myzilra, Alyacen 7 / 7 / 7, mestranol / norethindrone, Necon 0.5 / 35, Wymzya Fe, Norlyroc, Ovcon 50, Ortho-Novum 10 / 11, Deblitane, Incassia, ethinyl estradiol / ethynodiol, ethinyl estradiol / etonogestrel, Nortrel 0.5 / 35, Necon 10 / 11, Briellyn, ethinyl estradiol / norgestrel, Kurvelo, Wera, Nelova 1 / 50 M, Cycrin, Ergotrate Maleate, Jenest, Demulen 1 / 35, Demulen 1 / 50, Triphasil-21, Brevicon, Levlite, Nelova 0.5 / 35, Min-Ovral 21, Min-Ovral 28, Genora 0.5 / 35, Tri-Levlen, Genora 1 / 35, Norethin 1 / 50 M, Norinyl 1+50, Genora 1 / 50, Cyclafem 7 / 7 / 7, Demulen, Nelova 10 / 11, Loestrin 21 1.5 / 30, Curretab, Amen, Nordette-28, Norethin 1 / 35 E, Ergotrate, Nelova 1 / 35